Overview This page contains the latest trade data of Unpackaged Medicaments. In 2021, Unpackaged Medicaments were the world's 366th most traded product, with a total trade of $9.68B. Between 2020 and 2021 the exports of Unpackaged Medicaments decreased by -9.22%, from $10.7B to $9.68B. Trade in Unpackaged Medicaments represent 0.046% of total world trade.
Unpackaged Medicaments are a part of Pharmaceutical products. They include Medicaments nes, formulated, in bulk, Antibiotics nes, formulated, in bulk, Hormones nes, no antibiotics, bulk, not contraceptive, Penicillins or streptomycins and derivatives, in bulk, Alkaloids, derivs, without antibiotics, hormones, bul, and Insulin, formulated, in bulk.
Exports In 2021 the top exporters of Unpackaged Medicaments were United States ($1.33B), China ($901M), Germany ($686M), Switzerland ($557M), and Spain ($521M).
Imports In 2021 the top importers of Unpackaged Medicaments were United States ($836M), Germany ($821M), Ireland ($805M), United Kingdom ($541M), and Denmark ($322M).
Tariffs In 2018 the average tariff for Unpackaged Medicaments was 3.92%, making it the 1030th lowest tariff using the HS4 product classification.
Ranking Unpackaged Medicaments ranks 361st in the Product Complexity Index (PCI).
Description Examples of medicaments consisting of two or more constituents mixed together for therapeutic or prophylactic uses are antibiotics, which are used to treat bacterial infections, and vaccines, which are used to prevent diseases.
Unpackaged Medicaments